Michele Spinicci

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Alessio Mazzoni, Lorenzo Salvati, Laura Maggi et al. · Journal of Clinical Investigation · 2020 · 532 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19

Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi et al. · Journal of Clinical Investigation · 2021 · 149 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori et al. · European Journal of Internal Medicine · 2020 · 112 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +4

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Maria Carmela Piccirillo, Paolo A. Ascierto, Carlo Salvarani et al. · Journal of Translational Medicine · 2020 · 112 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study

Alessandra Vultaggio, Emanuele Vivarelli, Gianni Virgili et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 80 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16